(Reuters) -Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated ...

BB-1701 has survived Eisai’s decision not to option the HER2-directed antibody-drug conjugate. | BB-1701 has survived Eisai’s ...

Arlando “Tray” Jones is among thousands of people seeking accountability under a new state law that eliminated the statute of ...

Groups opposed to the bill have said it would effectively put a new $10.64 fee on prescriptions under the requirement to ...

One Stanford scientist quit academia to try to make medical cannabis better. Now he's selling millions of futuristic pot pills a year.

Telix Pharmaceuticals' said its new drug application in the U.S. for an imaging agent received regulatory approval. The Melbrourne, Australia-based biopharmaceutical company said Friday that the Food ...

Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.

A Yeadon man was sentenced to 7-14 years in a state prison Wednesday after pleading guilty to drug delivery resulting in ...

Three accused, who are brothers, are behind bars and habitual offenders with 15 cases registered against them.

A Florida man who killed an 8-year-old girl and her grandmother on a night in which he drank heavily and used drugs has been ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...